Autor: |
Schneider, J. S., Roeltgen, D. P., Mancall, E. L., Chapas-Crilly, J., Rothblat, D. S., Tatarian, G. T. |
Zdroj: |
Neurology (Ovid); June 1998, Vol. 50 Issue: 6 p1630-1636, 7p |
Abstrakt: |
Studies in animal models of Parkinson's disease (PD) suggest that GM1 ganglioside treatment can restore neurologic and dopaminergic function. In view of positive preclinical findings and the results of a previous open-label study demonstrating efficacy of GM1 in PD patients, this study compared effects of GM1 ganglioside and placebo on motor functions in PD patients. |
Databáze: |
Supplemental Index |
Externí odkaz: |
|